Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGNDZ) Operating Leases (2019 - 2025)

Ligand Pharmaceuticals (LGNDZ) has disclosed Operating Leases for 7 consecutive years, with $4.2 million as the latest value for Q4 2025.

  • Quarterly Operating Leases fell 41.24% to $4.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.2 million through Dec 2025, down 41.24% year-over-year, with the annual reading at $4.2 million for FY2025, 41.24% down from the prior year.
  • Operating Leases hit $4.2 million in Q4 2025 for Ligand Pharmaceuticals, down from $4.4 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $34.9 million in Q3 2022 to a low of $800000.0 in Q1 2025.
  • Historically, Operating Leases has averaged $9.7 million across 5 years, with a median of $6.2 million in 2023.
  • Biggest five-year swings in Operating Leases: soared 521.8% in 2022 and later crashed 84.59% in 2025.
  • Year by year, Operating Leases stood at $2.3 million in 2021, then skyrocketed by 358.16% to $10.3 million in 2022, then plummeted by 40.17% to $6.2 million in 2023, then rose by 15.69% to $7.2 million in 2024, then tumbled by 41.24% to $4.2 million in 2025.
  • Business Quant data shows Operating Leases for LGNDZ at $4.2 million in Q4 2025, $4.4 million in Q3 2025, and $4.6 million in Q2 2025.